- Home
- CADL vs LFCR Comparison
CADL vs LFCR Comparison
Compare CADL & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- LFCR
- Stock Information
- Founded
- CADL 1999
- LFCR 1986
- Country
- CADL United States
- LFCR United States
- Employees
- CADL N/A
- LFCR N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- CADL Health Care
- LFCR Health Care
- Exchange
- CADL Nasdaq
- LFCR Nasdaq
- Market Cap
- CADL 159.1M
- LFCR 164.3M
- IPO Year
- CADL 2021
- LFCR N/A
- Fundamental
- Price
- CADL $6.60
- LFCR $7.47
- Analyst Decision
- CADL Strong Buy
- LFCR Buy
- Analyst Count
- CADL 1
- LFCR 2
- Target Price
- CADL $11.00
- LFCR $10.00
- AVG Volume (30 Days)
- CADL 8.6M
- LFCR 195.3K
- Earning Date
- CADL 11-14-2024
- LFCR 10-04-2024
- Dividend Yield
- CADL N/A
- LFCR N/A
- EPS Growth
- CADL N/A
- LFCR N/A
- EPS
- CADL N/A
- LFCR 0.17
- Revenue
- CADL N/A
- LFCR $128,443,999.00
- Revenue This Year
- CADL N/A
- LFCR $2.23
- Revenue Next Year
- CADL N/A
- LFCR $8.40
- P/E Ratio
- CADL N/A
- LFCR $45.01
- Revenue Growth
- CADL N/A
- LFCR 23.42
- 52 Week Low
- CADL $1.02
- LFCR $3.68
- 52 Week High
- CADL $14.60
- LFCR $8.90
- Technical
- Relative Strength Index (RSI)
- CADL 55.49
- LFCR 56.70
- Support Level
- CADL $4.42
- LFCR $7.19
- Resistance Level
- CADL $7.28
- LFCR $7.88
- Average True Range (ATR)
- CADL 1.35
- LFCR 0.39
- MACD
- CADL 0.26
- LFCR -0.04
- Stochastic Oscillator
- CADL 22.48
- LFCR 55.91
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.